Clinical effect of chromium supplements on human health

The Nutritional Biochemistry of Chromium (III)

Volumn , Issue , 2007, Pages 163-181

  Cefalu, William T ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882895398     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-044453071-4/50009-6     Document Type: Chapter

References (84)

1. M.C. Riddle (2005) Glycemic Management of type 2 diabetes: An emerging strategy with oral agents, insulins and combinations. Endocrinol. Metab. Clin. North. Am. 34 77-98.
2. J.E. Gibson and D.A. Taylor (2005) Can Claims, misleading information and manufac-turing issues regulating dietary supplements be improved in the United States of America? J. Pharmacol. Exp. Ther. 314 939-944.
3. M.L. Neuhouser (2003) Dietary supplement use by Amercian women: Challenges in assess-ing patterns of use, motives and costs. J. Nutr. 133 1992S-1996S.
4. W.T. Cefalu and F.B. Hu (2004) Role of chromium in human health and in diabetes. Diabetes Care 27 2742-2751.
5. K. Schwarz and W. Mertz (1959) Chromium (III) and the glucose tolerance factor. Arch. Biochem. Biophys. 85 292-295.
6. R.W. Tuman and R.J. Doisy (1977) Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice. Diabetes 26 820-826.
7. K.N. Jeejeebhoy, R.C. Chu, E.B. Marliss, G.R. Greenberg and A. Bruce-Robertson (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parental nutrition. Am. J. Clin. Nutr. 30 531-538.
8. H. Freund, S. Atamian. and J.E. Fischer (1979) Chromium deficiency during total parenteral nutrition. JAMA 241 496-498.
9. R.A. Anderson (1995) Chromium and parenteral nutrition. Nutrition 11 83-86.
10. K. Kimura (1986) Role of essential trace elements in the disturbance of carbohydrate metabolism. Nippon Rinsho 54 79-84.
11. R.A. Anderson (1997) Nutritional factors influencing the glucose/insulin system: Chromium. J. Am. Coll. Nutr. 16 404-410.
12. D.A. American Diabetes Association. (2006) Standards of medical care in diabetes-2006. Diabetes Care 29 S4-S42
13. J.F. Potter, P. Levin, R.A. Anderson., J.M. Freiberg, R. Andres and D. Elahi (1985) Glucose metabolism in glucose-intolerant older people during chromium supplementation. Metabolism 34 199-204.
14. M.I. Uusitupa, L. Mykkanen, O. Siitonen, M. Laakso, H. Sarlund, P. Kolehmainen, T. Ras-sanen, J. Kumpulainen and K. Pyorälä (1992) Chromium supplementation in impaired glucose tolerance of elderly: Effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br. J. Nutr. 68 209-216.
15. B.E. Wilson and A. Gondy (1995) Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes. Res. Clin. Prac. 28 179-184.
16. M.B. Rabinowitz, H.C. Gonick, S.R. Levin and M.B. Davidson (1983) Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men. Diabetes Care 6 319-327.
17. L.G. Trow, J. Lewis, R.H. Greenwood., M.J. Sampson, K.A. Self, H.M. Crews and S.J. Fairweather-Tait (2000) Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes. Int. J. Vitam. Nutr. Res. 70 14-18.
18. L. Sherman, J.A. Glennon, W.J. Brech, G.H. Klomberg and E.S. Gordon (1968) Failure of trivalent chromium to improve hyperglycemia in diabetes mellitus. Metabolism 17 439-442.
19. M.I. Uusitupa, J.T. Kumpulainen, E. Voutilainen, K. Hersio, H. Sarlund, K.P. Pyorala, P.E. Koivistoinen and J.T. Lehto (1983) Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics. Am. J. Clin. Nutr. 38 404-410.
20. R.T. Mossop (1983) Effects of chromium (III) on fasting glucose, cholesterol and cholesterol HDL levels in diabetics. Cent. Afr. J. Med. 29 80-82.
21. R. Nath, J. Minocha, V. Lyall, S. Sunder, V. Kumar, S. Kapoor and K.L. Dhar (1979) Assessment of chromium metabolism in maturity onset and juvenile diabetes using chromium 51 and therapeutic response of chromium administration on plasma lipids, glucose tolerance and insulin levels. D. Shapcott, J. Hubert,(Eds) Chromium in Nutrition and Metabolism Amsterdam: Elsevier/North Holland 213-222.
22. W.H. Glinsmann and W. Mertz (1966) Effect of trivalent chromium on glucose tolerance. Metabolism 15 510-520.
23. P. Amato, A.J. Morales and S.S. Yen (2000) Effects of chromium picolinate supplemen-tation on insulin sensitivity, serum lipids, and body composition in healthy, nonobese, older men and women. J. Gerontol. A Biol. Sci. Med. Sci. 55 M260-M263
24. L. Jovanovic, M. Gutierrez and C.M. Peterson (1999) Chromium supplementation for women with gestational diabetes mellitus. J. Trace Elem. Exp. Med. 12 91-97.
25. A. Ravina, L. Slezak., N. Mirsky, N.A. Bryden and R.A. Anderson (1999) Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabet. Med. 16 164-167.
26. B.W. Morris, S. Kouta, R. Robinson, S. MacNeil and S. Heller (2000) Chromium supplementation improves insulin resistance in patients with type 2 diabetes mellitus. Diabet. Med. 17 684-685.
27. N. Cheng, X. Zhu, H. Shi, W. Wu, J. Chi, J. Cheng and R. Anderson (1999) Follow-up survey of people in China with type 2 diabetes mellitus consuming supplemental chromium. J. Trace Elem. Exp. Med. 12 55-60.
28. R.A. Anderson (1998) Chromium, glucose intolerance and diabetes. J. Am. Coll. Nutr. 17 548-555.
29. B.W. Morris, S. MacNeil, K. Stanley, T.A. Gray and R. Fraser (1993) The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J. Endocrinol. 139 339-345.
30. W.T. Cefalu, A.D. Bell-Farrow, J. Stegner, Z.Q. Wang, T. King, T. Morgan and J.G. Terry (1999) Effect of chromium picolinate on insulin sensitivity in vivo. J. Trace Elem. Exp. Med. 12 71-83.
31. L. Rossetti, A. Giaccari and R.A. DeFronzo (1990) Glucose toxicity. Diabetes Care 13 610-630. 1990
32. S.E. Inzucchi, D.G. Maggs, G.R. Spollett, S.L. Page, F.S. Rife, V. Walton and G.I. Shulman (1998) Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N. Engl. J. Med. 338 867-872.
33. W.T. Cefalu, A.D. Bell-Farrow, Z.Q. Wang, D. McBride, D. Dalgleish and J.G. Terry (1998) Effect of glipizide GITS on insulin sensitivity, glycemic indices, and abdominal fat composition in NIDDM. Drug Dev. Res. 44 1-7.
34. R.A. Anderson, N. Cheng, N.A. Bryden, M.M. Polansky, J. Chi and J. Feng (1997) Ele-vated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes 46 1786-1791.
35. D. Ghosh, B. Bhattacharya, B. Mukherjee, B. Manna, M. Sinha, J. Chowdhury and S. Chowdhury (2002) Role of chromium supplementation in Indians with type 2 diabetes mellitus. J. Nutr. Biochem. 13 690-697.
36. A. Ravina, L. Slezak, A. Rubal and N. Mirsky (1995) Clinical use of the trace element chromium (III) in the treatment of diabetes mellitus. J. Trace Elem. Exp. Med. 8 183-190.
37. S.M. Bahijri and A.M. Mufti (2002) Beneficial effects of chromium in people with type 2 diabetes, and urinary chromium response to glucose load as a possible indicator of status. Biol. Trace Elem. Res. 85 97-109.
38. S.M. Bahijri, S.A. Mira, A.M. Mufti and M.A. Ajabnoor (2000) The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med. J. 21 831-837.
39. S.H. Chen, Y.P. Sun and X.S. Chen (1997) Effect of jiangtangkang on blood glucose, sensitivity of insulin and blood viscosity in non-insulin dependent diabetes mellitus [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi 17 666-668.
40. A.S. Abraham, B.A. Brooks and U. Eylath (1992) The effects of chromium supplementa-tion on serum glucose and lipids in patients with and without non-insulin-dependent diabetes. Metabolism 41 768-771.
41. N.A. Lee and C.A. Reasner (1994) Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 17 1449-1452.
42. R.A. DeFronzo (1992) Insulin resistance, hyperinsulinemia, and coronary artery disease: A complex metabolic web. J. Cardiovasc. Pharmacol. 20(Supplement 11), S1-S16
43. G.M. Reaven (1988) Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 37 1595-1607.
44. S.M. Haffner (1996) The insulin resistance syndrome revisited. Diabetes Care 19 275-277.
45. A.D. Liese, E.J. Mayer-Davis and S.M. Haffner (1998) Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol. Rev. 20 157-172.
46. B. Isomaa, P. Almgren, T. Tuomi, B. Forsén, K. Lahti, M. Nissén, M-R. Taskinen and L. Groop (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 683-689.
47. The National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, And Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 2486-2497.
48. S.J. Hunter and W.T. Garvey (1998) Insulin action and insulin resistance: Diseases involving defects in insulin receptors, signal transduction, and the glucose transport effector system. Am. J. Med. 105 331-345.
49. J.E. Gunton, N.W. Cheung, R. Hitchman, G. Hams, C. O'Sullivan, K. Foster-Powell and A. McElduff (2005) Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: A randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28 712-713.
50. J. Komorowski and V. Juturu (2005) Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: A randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care 28 1841-1842.
51. S.L. Volpe, H.W. Huang, K. Larpadisorn and I.I. Lesser (2001) Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J. Am. Coll. Nutr. 20 293-306.
52. E.G. Offenbacher and F.X. Pi-Sunyer (1980) Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects. Diabetes 29 919-925.
53. M.D. Althuis, N.E. Jordan, E.A. Ludington and J.T. Wittes (2002) Glucose and insulin responses to dietary chromium supplements: A meta-analysis. Am. J. Clin. Nutr. 76 148-155.
54. R.A. Anderson (2003) Chromium and insulin sensitivity. Nutr. Res. Rev. 16 267-275.
55. V. Juturu and J.R. Komorowski (2003) Chromium supplements, glucose, and insulin responses. Am. J. Clin. Nutr. 78 190-193.
56. W.T. Cefalu, Z.Q. Wang, X.H. Zhang, L.C. Baldor and J.C. Russell (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic (JCR-LA Corpu. J. Nutr. 132 1107-1114.
57. Z.Q. Wang, X.H. Zhang, J.C. Russell, M. Hulver and W.T. Cefalu (2006) Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin resistant JCR:LA-cp rat. J. Nutr. 136.
58. Z.Q. Wang, X.H. Zhang, J.C. Russell, M. Hulver and W.T. Cefalu (2006) Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin resistant JCR:LA-cp rat. J. Nutr. 415-420.
59. D.C.P.C.D.C. Centers for Disease Control , Prevention.(CDC) (2003) Diabetes prevalence among American Indians and Alaska Natives and the overall population—United States, 1994–2002. MMWR Morb. Mortal Wkly. Rep. 52 702-704.
60. A.H. Mokdad, E.S. Ford, B.A. Bowman, W.H. Dietz, F. Vinicor, V.S. Bales and J.S. Marks (2003) Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 76-79.
61. E.S. Ford, W.H. Giles and W.H. Dietz (2002) Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 287 356-359.
62. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation WHO Technical Report Series 894 Geneva, Switzerland: World Health Organization
63. R.M. Evans, G.D. Barish and Y.U. Wang (2004) PPARs and the complex journey to obesity. Nat. Med. 10 355-361.
64. V. Crawford, R. Scheckenbach and H.G. Preuss (1999) Effects of niacin-bound chromium supplementation on body composition in overweight African-American women. Diabetes Obes. Metab. 1 331-337.
65. W.W. Campbell, L.J. Joseph, R.A. Anderson, S.L. Davey, J. Hinton and W.J. Evans (2002) Effects of resistive training and chromium picolinate on body composition and skeletal muscle size in older women. Int. J. Sport Nutr. Exerc. Metab. 12 125-135.
66. H.C. Lukaski, W.W. Bolonchuk, W.A. Siders and D.B. Milne (1996) Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am. J. Clin. Nutr. 63 954-965.
67. M.A. Hallmark, T.H. Reynolds, C.A. DeSouza, C.O. Dotson, R.A. Anderson and M.A. Rogers (1996) Effects of chromium and resistive training on muscle strength and body composition. Med. Sci. Sports Exerc. 28 139-144.
68. G.R. Kaats, K. Blum, J.A. Fisher and J.A. Adelman (1996) Effects of chromium picolinate supplementation on body composition: a randomized, double-masked placebo-controlled study. Curr. Ther. Res. 57 747-756.
69. G.R. Kaats, K. Blum, D. Pullin, S.C. Keith and R. Woods (1998) A randomized, double-masked, placebo-controlled study of the effects of chromium picolinate supplementation on body composition: A replication and extension of a previous study. Curr. Ther. Res. 59 379-388.
70. M.H. Pittler, C. Stevinson and E. Ernst (2003) Chromium picolinate for reducing body weight: Meta-analysis of randomized trials. Int. J. Obes. Relat Metab Disord. 27 522-529.
71. J.R. Roeback Jr., K.M. Hla, L.E. Chambless and R.H. Fletcher (1991) Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers: A randomized, controlled trial. Ann. Intern. Med. 115 917-924.
72. G.W. Evans (1989) The effect of chromium picolinate on insulin controlled parameters in humans. Int. J. Biosoc. Med. Res. 11 163-180.
73. R. Riales and M.J. Albrink (1981) Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am. J. Clin. Nutr. 34 2670-2678.
74. R.I. Press, J. Geller and G.W. Evans (2000) The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. West. J. Med. 152 41-45.
75. H.G. Preuss, D. Wallerstedt. and N. Talpur (2000) Effects of niacin-bound chromium and grape seed proanthocyanidin extract on the lipid profile of hypercholesterolemic subjects: A pilot study. J. Med. 31 227-246.
76. E.B. Rimm, E. Guallar, E. Giovannucci, A. Ascherio, M.J. Stampfer, W.C. Willet and F. Hu (2002) Toenail chromium levels and risk of coronary heart disease among normal and overweight men. Presented at the American Heart Association 42nd Annual Conference on Cardiovascular Disease, Epidemiology and Prevention 23–26 April 2002, Honolulu, Hawaii
77. S. Rajpathak, E.B. Rimm, T. Li, J.S. Morris, M.J. Stampfer, W.C. Willett and F.B. Hu (2004) Lower toenail chromium in men with diabetes and cardiovascular disease compared with healthy men. Diabetes Care 27 2211-2216.
78. E. Guallar, F.J. Jimenez, P. van't Veer, P. Bode, R.A. Riemersma, J. Gomez-Aracena, J.D. Kark, L. Arab, F.J. Kok and J.M. Martin-Moreno (2005) EURAMIC-Heavy Metals and Myocardial Infraction Study Group. Low toenail chromium concentration and increased risk of nonfatal myocardial infarction. Am. J. Epidemiol. 162 157-164.
79. E.S. Paykel, P.S. Mueller and V.P.M. De la Vergne P.M. (1973) Amitriptyline, weight gain and carbohydrate craving: a side effect. Br. J. Psychiatry 123 501-507.
80. M.J. Attenburrow, J. Odontiadis, B.J. Murray, P.J. Cowen and M. Franklin (2002) Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology (Berl) 159 432-436.
81. J.R. Davidson, K. Abraham, K.M. Connor and M.N. McLeod (2003) Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol. Psychiatry 5 261-264.
82. J.P. Docherty, D.A. Sack, M. Roffman, M. Finch and J.R. Komorowski (2005) A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J. Psychiatr. Pract. 11 302-314.
83. J. Martin, Z.Q. Wang, X.H. Zhang, D. Wachtel, J. Volaufova, D.E. Matthews. and W.T. Cefalu (2006) Chromium picolinate supplementation attenuates body weight gain and increase insulin sensitivity with type 2 diabetes. Diabetes Care 29 1826-1832.
84. N. Kleefstra, S.T. Houweling., F.G.A. Jansman, K.H. Groenier, R.O.B. Gans, J.B. Meyboom-de Jong. B., S.J.L. Bakker and H.J.G. Bilo (2006) Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial. Diabetes Care 29 521-525.